Local health workers to receive training
31 March 2014, 22:24
Nairobi - One of the world’s leading research-based pharmaceutical and healthcare companies announced plans to train and upskill thousands of community healthcare workers across Kenya, Ghana and Nigeria.
GSK said the training of the 10 000 workers would be done in with local charities under the auspices of the One Million Community Health Worker campaign, a United Nations-led initiative.
According to officials, the investment would be targeted at supporting the most remote and marginalised communities to help address healthcare inequalities that exist even in fast-growing countries.
These changes, GSK stated, build on steps taken by GSK over the past six years to modernise its business model and help improve access to medicines in developing countries. This has seen the company cap the prices of its patented medicines at no more than 25 percent of developed world prices and reinvest 20 percent of any profit made back into training healthcare workers in the world’s poorest countries.
“Today, we are setting out further steps to tackle Africa’s dual health burden of infectious and emerging non-communicable diseases and help build crucial capacity to underpin the development of the healthcare sector in the region. We have a unique opportunity to deliver meaningful social and economic value to all of the communities we work in – using our scientific expertise and our global reach to develop innovative medicines and deliver them to people who need them around the world,” stated GSK CEO, Sir Andrew Witty, in a statement released after the 5th EU-Africa Business Forum in Brussels.
“With global attention focused on how we support development beyond 2015, now is the moment for business to play a more active role in contributing to a more prosperous future in Africa, investing in infrastructure, building skills and capability to unlock human potential and create jobs.
Our long-term goal is to equip Africa to discover, develop and produce the medicines required for Africa.”
GSK pledged to invest up to £130 million in Africa over the next five years, creating at least 500 jobs and contributing to the development of home-grown capabilities and skills in Africa. This builds on GSK’s existing business base in sub-Saharan Africa, which currently employs around 1 500 people in over 40 countries, including at three existing local manufacturing sites in Kenya, Nigeria and South Africa.
– CAJ News